Hastings Equity Partners, LLC
Alex Tancredi is a seasoned professional with extensive experience in strategic roles across various companies in the biotechnology and investment sectors. Currently serving as Principal at Hastings Equity Partners, LLC, Alex has previously held positions as VP at Curie.Bio and VP, Head of Strategy and Business Development at Octant. Alex's career also includes significant roles at Relay Therapeutics, where responsibilities encompassed Director of Corporate Development and Strategy and Associate Director of Business Development. Earlier experience includes a position as a Private Equity Investor, Associate at Charlesbank Capital Partners. Alex holds a BA in Neuroscience/Psychology from Harvard University and an MBA from Stanford University Graduate School of Business.
This person is not in the org chart
This person is not in any teams
Hastings Equity Partners, LLC
Founded in 2004, Hastings Equity Partners is a lower middle-market private equity firm. Hastings invests first institutional capital in North American founder-led companies within the industrial and business services sectors, where it has deep operating and investing experience. As a preferred capital partner, Hastings seeks to empower businesses to reach their full potential. For almost two decades, the firm has formed long-term partnerships with entrepreneurs while utilizing a hands-on approach to enhance operations, provide strategic support, and accelerate growth.